Search the GHTC website

Global health R&D delivers for New Mexico

US government investment in global health R&D has delivered

$24.3 million
to New Mexico research institutions
250+ new jobs
for New Mexico
New Mexico's top USG-funded global health R&D institutions

New Mexico's top USG-funded global health R&D institutions

University of New Mexico
$18.4 million
Los Alamos Scientific Laboratory
$4.9 million
The National Center for Genome Resources
$497 thousand
Santa Fe Institute
$362 thousand
The Lovelace Respiratory Research Institute (including Lovelace Biomedical and Environmental Research)
$49 thousand
New Mexico industry in global health R&D

New Mexico industry in global health R&D

Location(s): Albuquerque
Creative LIBS Solution
Location(s): Bernalillo
Mesa Biotech
Location(s): Santa Fe
VisionQuest Biomedical
Location(s): Albuquerque

New Mexico's top areas of global health R&D by USG funding

Neglected tropical diseases
Diarrheal diseases
Ebola/viral hemorrhagic fevers
Global health R&D at work in New Mexico

University of New Mexico researchers have developed a rapid breath test to detect tuberculosis and other lung diseases, such as pneumonia. The noninvasive, easy-to-use test offers results in 10 minutes without need for expensive laboratory equipment. The test is a major step forward in terms of speed and portability. It will enable doctors in low-resource settings to quickly detect lung infections and get patients on treatment. The technology has led to the creation of a company headquartered in Santa Fe which plans to commercialize the test, highlighting the economic returns of global health research.

  • Methodology
  • USG global health R&D investment to state research institutions/Top USG-funded global health R&D institutions: Authors' analysis of USG investment data from the G-FINDER survey, including funding for R&D for neglected diseases from 2007–2015 and for Ebola and select viral hemorrhagic fevers from 2014–2015. Reflects USG funding received by entities in state including academic and research institutions, product development partnerships, other nonprofits, select corporations, and government research institutions, as well as self-funding or other federal agency transfers received by federal agencies located in state; but excludes pharmaceutical industry data which is aggregated and anonymized in the survey for confidentiality purposes. See methodology for additional details.
  • Jobs created: Based on previous analysis of the economic impact of National Institutes of Health R&D funding and author's analysis described above. See methodology for additional details.
  • Case study photo: USAID South Africa